I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Immuno-priming durvalumab with bevacizumab in HER2-negative..:
Quintela-Fandino, Miguel
;
Holgado, Esther
;
Manso, Luis
...
Ministerio de Economía, Industria y Competitividad PI16/00354. , 2020
Link:
https://ddd.uab.cat/record/253078
RT Journal T1
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer : a pilot clinical trial
UL https://suche.suub.uni-bremen.de/peid=base-ftuabarcelonapb:oai:ddd.uab.cat:253078&Exemplar=1&LAN=DE A1 Quintela-Fandino, Miguel A1 Holgado, Esther A1 Manso, Luis A1 Morales, Serafin A1 Bermejo, Begoña A1 Colomer, Ramon A1 Apala, Juan V A1 Blanco, Raquel A1 Muñoz, Manuel A1 Caleiras, Eduardo A1 Iranzo, Vega A1 Martínez López, Mario A1 Dominguez, Orlando A1 Hornedo, Javier A1 Gonzalez-Cortijo, Lucia A1 Cortés, Javier A1 Gasol Cudos, Ariadna A1 Malon, Diego A1 Lopez-Alonso, Antonio A1 Moreno-Ortíz, María C A1 Mouron, Silvana A1 Mañes, Santos A1 Universitat Autònoma de Barcelona YR 2020 K1 Durvalumab K1 Bevacizumab K1 HER2-negative breast cancer K1 Vascular normalization K1 Immuno-priming JF Ministerio de Economía, Industria y Competitividad PI16/00354 LK http://dx.doi.org/https://ddd.uab.cat/record/253078 DO https://ddd.uab.cat/record/253078 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)